孙
孙化斌 Chief Executive Officer
C-suite
FR FR · AMF
Browse the full record of transactions filed by 孙化斌, Chief Executive Officer. Director active across 1 companies, notably 双星新材. Cumulatively, 46 filings have been published. The latest transaction was filed on 25 April 2025 — Purchase. Regulator: AMF. All data is accessible without signup.
Declarations 46 total
80,000 shares
SSE:173000009835496400 · 27 Nov 2025
30,000 shares
SSE:173000009827576740 · 24 Nov 2025
30,000 shares
SSE:173000009783837660 · 17 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 8,000 shares
SSE:173000009783837730 · 17 Nov 2025
10,000 shares
SSE:173000009775577400 · 13 Nov 2025
69,900 shares
SSE:173000009738442370 · 11 Nov 2025
20,000 shares
SSE:173000009726371520 · 10 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 20,000 shares
SSE:173000009717809440 · 6 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 10,000 shares
SSE:173000009717809470 · 6 Nov 2025
6,000 shares
SSE:173000009717809800 · 6 Nov 2025
50,000 shares
SSE:173000009712471970 · 5 Nov 2025
Executives ● Purchase派 派林生物 18 SZSE €19,584 7,500 shares
SZSE:173000008868500580 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase派 派林生物 22 SZSE €13,056 5,000 shares
SZSE:173000008868500400 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase派 派林生物 7 SZSE €542 200 shares
SZSE:173000008717793300 · 24 Feb 2025
Ideal exit: 21 Nov 2025 (T+270) Executives ● Purchase派 派林生物 7 SZSE €5,572 2,000 shares
SZSE:173000008552387420 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €4,321 1,500 shares
SZSE:173000008451201340 · 14 Jan 2025
Ideal exit: 11 Oct 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €2,185 800 shares
SZSE:173000008409120800 · 7 Jan 2025
Ideal exit: 4 Oct 2025 (T+270) Executives ● Purchase派 派林生物 11 SZSE €27,529 10,000 shares
SZSE:173000008405393340 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase派 派林生物 7 SZSE €5,506 2,000 shares
SZSE:173000008405393300 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase派 派林生物 11 SZSE €14,076 5,000 shares
SZSE:173000008396452540 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €5,631 2,000 shares
SZSE:173000008396452580 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Purchase尤 尤夫股份 11 SZSE 5,700 shares
SZSE:173000008264542800 · 14 Nov 2024
Ideal exit: 11 Aug 2025 (T+270) Executives ● Purchase尤 尤夫股份 7 SZSE 4,000 shares
SZSE:173000008138114020 · 30 Sept 2024
Ideal exit: 27 Jun 2025 (T+270) Executives ● Purchase尤 尤夫股份 7 SZSE 8,000 shares
SZSE:173000007882566600 · 25 Jul 2024
Ideal exit: 21 Apr 2025 (T+270) Executives ● Sale派 派林生物 7 SZSE 3,500,000 shares
SZSE:173000006682573300 · 26 Jun 2023
25 of 46 declarations
Load more (21 remaining) About 孙化斌 Sun Huabin is the Chief Executive Officer of Shuangxing New Materials, where he leads strategic and operational initiatives. His expertise contributes to the company's innovation and growth.